Followup of neutrophil-to-lymphocyte ratio and recurrence of clear cell renal cell carcinoma

Journal of Urology

Volumn 187, Issue 2, 2012, Pages 411-417

  Ohno, Yoshio ^a   Nakashima, Jun ^a   Ohori, Makoto ^a   Gondo, Tatsuo ^a   Hatano, Tadashi ^a   Tachibana, Masaaki ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

carcinoma; kidney; lymphocytes; neutrophils; prognosis; renal cell

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CELLULAR PARAMETERS; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEUTROPHIL; NEUTROPHIL TO LYMPHOCYTE RATIO; NONMETASTATIC CLEAR CELL RENAL CELL CARCINOMA; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; TUMOR VOLUME;

ADULT; CARCINOMA, RENAL CELL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; LEUKOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUTROPHILS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84855576660     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.10.026     Document Type: Article

References (29)

1. A. Jemal, R.C. Tiwari, T. Murray et al. Cancer statistics, 2004 CA Cancer J Clin 54 2004 8
2. N.K. Janzen, H.L. Kim, R.A. Figlin et al. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease Urol Clin North Am 30 2003 843
3. A. Mantovani, P. Allavena, A. Sica et al. Cancer-related inflammation Nature 454 2008 436
4. L.M. Biasucci CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper Circulation 110 2004 e560
5. H. Tilg, A.R. Moschen Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis Hepatology 52 2010 1836
6. C. Cray, J. Zaias, N.H. Altman Acute phase response in animals: a review Comp Med 59 2009 517
7. A. Casamassima, M. Picciariello, M. Quaranta et al. C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy J Urol 173 2005 52
8. D.C. McMillan, K. Canna, C.S. McArdle Systemic inflammatory response predicts survival following curative resection of colorectal cancer Br J Surg 90 2003 215
9. B.L. Pierce, M.L. Neuhouser, M.H. Wener et al. Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors Breast Cancer Res Treat 114 2009 155
10. Y. Komai, K. Saito, K. Sakai et al. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma BJU Int 99 2007 77
11. R. Zahorec Ratio of neutrophil to lymphocyte countsrapid and simple parameter of systemic inflammation and stress in critically ill Bratisl Lek Listy 102 2001 5
12. S.R. Walsh, E.J. Cook, F. Goulder et al. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer J Surg Oncol 91 2005 181
13. H. Ubukata, G. Motohashi, T. Tabuchi et al. Evaluations of interferon-gamma/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients J Surg Oncol 102 2010 742
14. H. Cho, H.W. Hur, S.W. Kim et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment Cancer Immunol Immunother 58 2009 15
15. S.C. Kao, N. Pavlakis, R. Harvie et al. High blood neutrophil-to- lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy Clin Cancer Res 16 2010 5805
16. Y. Ohno, J. Nakashima, M. Ohori et al. Pretreatment neutrophil-to- lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma J Urol 184 2010 873
17. F.L. Greene, D.L. Page, I.D. Fleming AJCC Cancer Staging Manual 6th ed. 2002 Springer-Verlag New York
18. S.A. Fuhrman, L.C. Lasky, C. Limas Prognostic significance of morphologic parameters in renal cell carcinoma Am J Surg Pathol 6 1982 655
19. A. Lopez-Beltran, M. Scarpelli, R. Montironi et al. 2004 WHO classification of the renal tumors of the adults Eur Urol 49 2006 798
20. J. Atzpodien, P. Royston, T. Wandert et al. Metastatic renal carcinoma comprehensive prognostic system Br J Cancer 88 2003 348
21. T.V. Johnson, A. Abbasi, A. Owen-Smith et al. Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma Urology 76 2010 766
22. M. Hara, A. Yonei, T. Ayabe et al. Postoperative serum C-reactive protein levels in non-small cell lung cancer patients Ann Thorac Cardiovasc Surg 16 2010 85
23. A. Volpe, J.J. Patard Prognostic factors in renal cell carcinoma World J Urol 28 2010 319
24. M.H. Bui, D. Seligson, K.R. Han et al. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy Clin Cancer Res 9 2003 802
25. L. Cindolo, A. de la Taille, G. Messina et al. A preoperative clinical prognostic model for non-metastatic renal cell carcinoma BJU Int 92 2003 901
26. I. Frank, M.L. Blute, J.C. Cheville et al. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score J Urol 168 2002 2395
27. M.W. Kattan, V. Reuter, R.J. Motzer et al. A postoperative prognostic nomogram for renal cell carcinoma J Urol 166 2001 63
28. O. Yaycioglu, W.W. Roberts, T. Chan et al. Prognostic assessment of nonmetastatic renal cell carcinoma: a clinically based model Urology 58 2001 141
29. A. Zisman, A.J. Pantuck, J. Wieder et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma J Clin Oncol 20 2002 4559